DD202032A5 - Verfahren zur herstellung von makroliden - Google Patents

Verfahren zur herstellung von makroliden Download PDF

Info

Publication number
DD202032A5
DD202032A5 DD81234840A DD23484081A DD202032A5 DD 202032 A5 DD202032 A5 DD 202032A5 DD 81234840 A DD81234840 A DD 81234840A DD 23484081 A DD23484081 A DD 23484081A DD 202032 A5 DD202032 A5 DD 202032A5
Authority
DD
German Democratic Republic
Prior art keywords
omt
acid
dmt
dihydro
deoxy
Prior art date
Application number
DD81234840A
Other languages
German (de)
English (en)
Inventor
Richard H Baltz
Herbert A Kirst
Gene M Wild
Eugene T Seno
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD202032A5 publication Critical patent/DD202032A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/54—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DD81234840A 1980-11-10 1981-11-10 Verfahren zur herstellung von makroliden DD202032A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/205,539 US4304856A (en) 1980-11-10 1980-11-10 Process for producing 20-dihydro-20-deoxy-23-demycinosyltylosin

Publications (1)

Publication Number Publication Date
DD202032A5 true DD202032A5 (de) 1983-08-24

Family

ID=22762621

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81234840A DD202032A5 (de) 1980-11-10 1981-11-10 Verfahren zur herstellung von makroliden

Country Status (22)

Country Link
US (1) US4304856A (xx)
EP (1) EP0052005B1 (xx)
JP (1) JPS57108097A (xx)
KR (1) KR850001666B1 (xx)
AR (1) AR227563A1 (xx)
AU (1) AU7731381A (xx)
BG (1) BG36939A3 (xx)
CA (1) CA1169374A (xx)
CS (1) CS236663B2 (xx)
DD (1) DD202032A5 (xx)
DE (1) DE3168693D1 (xx)
DK (1) DK494381A (xx)
FI (1) FI813527L (xx)
GB (1) GB2086902B (xx)
GR (1) GR75386B (xx)
HU (1) HU190360B (xx)
IE (1) IE51826B1 (xx)
IL (1) IL64240A (xx)
PH (1) PH17375A (xx)
PL (1) PL233747A1 (xx)
PT (1) PT73947B (xx)
ZA (1) ZA817718B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419508A (en) * 1980-11-10 1983-12-06 Eli Lilly And Company 20-Dihydro-20-deoxy-23-demycinosyltylosin and process for its production
AU551142B2 (en) * 1981-07-09 1986-04-17 Zaidan Hojin Biseibutsu Kagaku Kenkyukai Tylosin derivatives
US4423148A (en) * 1982-07-02 1983-12-27 Eli Lilly And Company Process for producing 20-dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US4528369A (en) * 1982-07-02 1985-07-09 Eli Lilly And Company 20-Dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US4452784A (en) * 1982-07-19 1984-06-05 Eli Lilly And Company C-23-Modified derivatives of DMT
US4443436A (en) * 1982-09-13 1984-04-17 Eli Lilly And Company C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin
US4629786A (en) * 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
US4468511A (en) * 1983-02-28 1984-08-28 Eli Lilly And Company C-20- And C-23-Modified macrolide derivatives
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
ATE151767T1 (de) * 1993-07-15 1997-05-15 Pfizer Amid-derivate von 16-gliedrige heterocyclen als antibiotische macrolide
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178341A (en) * 1960-06-27 1965-04-13 Lilly Co Eli Antibiotics tylosin and desmycosin and derivatives thereof
US3326759A (en) * 1962-07-19 1967-06-20 Lilly Co Eli Antibiotics macrocin and lactenocin
US3344024A (en) * 1963-04-17 1967-09-26 American Cyanamid Co Antibiotic am-684 and method of production
BE667952A (xx) * 1964-08-05
US4161523A (en) * 1972-11-15 1979-07-17 Schering Corporation Rosamicin esters, acid addition salts and methods for production thereof
US4056616A (en) * 1976-03-05 1977-11-01 Schering Corporation Rosamicin derivatives and method of using same
GB1587685A (en) * 1977-03-09 1981-04-08 Microbial Chem Res Found Macrolactone derivatives and their production
US4252898A (en) * 1979-05-23 1981-02-24 Eli Lilly And Company Antibiotics A6888C and A6888X
NL8004922A (nl) * 1979-09-19 1981-03-23 Toyo Jozo Kk Deformyltylosinederivaten.

Also Published As

Publication number Publication date
CS236663B2 (en) 1985-05-15
IL64240A (en) 1985-08-30
EP0052005A1 (en) 1982-05-19
EP0052005B1 (en) 1985-01-30
KR830007833A (ko) 1983-11-07
FI813527L (fi) 1982-05-11
BG36939A3 (en) 1985-02-15
GR75386B (xx) 1984-07-13
KR850001666B1 (ko) 1985-11-13
IE812616L (en) 1982-05-10
GB2086902B (en) 1985-06-26
GB2086902A (en) 1982-05-19
ZA817718B (en) 1982-10-27
IL64240A0 (en) 1982-02-28
AU7731381A (en) 1982-05-20
DK494381A (da) 1982-05-11
PH17375A (en) 1984-08-06
PL233747A1 (xx) 1982-11-22
JPS57108097A (en) 1982-07-05
CA1169374A (en) 1984-06-19
DE3168693D1 (en) 1985-03-14
PT73947B (en) 1983-11-30
IE51826B1 (en) 1987-04-01
HU190360B (en) 1986-08-28
US4304856A (en) 1981-12-08
AR227563A1 (es) 1982-11-15
PT73947A (en) 1981-12-01

Similar Documents

Publication Publication Date Title
DE2347682C2 (de) Rapamycin, Verfahren zu seiner Herstellung und pharmazeutisches Mittel
DE2634499C2 (de) Tylosin-Acylderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen und Tierfutterzubereitungen
DD159644A5 (de) Verfahren zur herstellung von makroliden
DD202032A5 (de) Verfahren zur herstellung von makroliden
DE2167325C2 (de) Antibiotikum A-201B und Verfahren zu seiner Herstellung
DE2918711C2 (xx)
DE2336811C2 (de) Antibiotikum A-2315, Verfahren zu seiner Herstellung und seine Verwendung
DE2839668C2 (xx)
DD202047A5 (de) Verfahren zur herstellung des makrolids 20-dihydro-20,23-dideoxytylonolid
DE2004686B2 (de) Makrolid-Antibioticum SF-837 und dessen Diacetylderivat und deren pharmakologisch nichtgiftige Säureanlagerungssalze sowie Verfahren zur Herstellung des Antibioticums SF-837
DD159645A5 (de) Verfahren zur herstellung von makroliden
DE2252937A1 (de) Antibioticum a477 und verfahren zu seiner herstellung
EP0236894B1 (de) Efomycin G, seine Herstellung und seine Verwendung als Leistungsförderer bei Tieren
DD202452A5 (de) Verfahren zur herstellung von makroliden
DD140477A5 (de) Verfahren zur herstellung von a-40104-antibiotika und derivaten davon
DE2654266C3 (de) Verfahren zur mikrobiologischen Herstellung von 5,10,11,1 la-Tetrahydro-9,1 ldihydroxy-e-methyl-Soxo-lH-pyrrolo [2,1-c] [1,4] benzodiazepin-2acrylamid
DE2014277A1 (de) Verfahren zur Herstellung von Acylderivaten des Antibiotikums T-2636 C
DE2209018A1 (de) Neues Antibioticum A-4696
AT312167B (de) Verfahren zur Herstellung neuer Antibiotika
DE966635C (de) Herstellung und Gewinnung des Antibiotikums Carbomycin
AT364455B (de) Verfahren zur herstellung von neuen phosphonsaeuren
DD206563A5 (de) Verfahren zur herstellung von makroliden
AT220293B (de) Verfahren zur Herstellung eines neuen Antibiotikums
DE920934C (de) Verfahren zur Erzeugung eines Antibiotikums und dessen Salzen
DE941013C (de) Verfahren zur Herstellung von Erythromycin B